Modulation of ABCA1 by an LXR agonist reduces ?-amyloid levels and improves outcome after traumatic brain injury.
Modulation of ABCA1 by an LXR agonist reduces ?-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma. 2011 Feb; 28(2):225-36.